These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6130674)

  • 21. Beta-adrenoceptor blockade and intrinsic sympathomimetic activity--relevance in the treatment of ischaemic heart disease.
    Northcote RJ; Ballantyne D
    Scott Med J; 1985 Oct; 30(4):208-15. PubMed ID: 2869581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrinsic sympathomimetic activity: clinical fact or fiction?
    Taylor SH
    Am J Cardiol; 1983 Nov; 52(9):16D-26D. PubMed ID: 6139009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug therapy of cardiovascular diseases and sports].
    Rost R
    Internist (Berl); 1992 Mar; 33(3):136-41. PubMed ID: 1349878
    [No Abstract]   [Full Text] [Related]  

  • 24. Interaction between simvastatin and metoprolol with respect to cardiac beta-adrenoceptor density, catecholamine levels and perioperative catecholamine requirements in cardiac surgery patients.
    Nette AF; Abraham G; Ungemach FR; Oertel R; Kirch W; Leineweber K; Mohr FW; Dhein S
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Aug; 372(2):115-24. PubMed ID: 16215713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The importance of the myocardial adrenoreceptors and their therapeutic significance].
    Brodde OE
    Klin Anasthesiol Intensivther; 1991; 41():72-80. PubMed ID: 1685756
    [No Abstract]   [Full Text] [Related]  

  • 26. [Beta-adrenergic blockers].
    Belovezhdov N
    Vutr Boles; 1986; 25(4):14-22. PubMed ID: 2876553
    [No Abstract]   [Full Text] [Related]  

  • 27. Withdrawal of chronic beta-adrenoceptorblockade: effects on haemodynamics, blood lipids and haemostatic variables.
    Smith P; Seljeflot I; Opstad T
    Eur J Clin Pharmacol; 1990; 39(1):81-2. PubMed ID: 1980463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Specific and nonspecific effects of beta receptor blockers: stereoselectively different properties exemplified by (R)- and (S)-propranolol].
    Stoschitzky K; Lindner W
    Wien Med Wochenschr; 1990 Apr; 140(6-7):156-62. PubMed ID: 1971978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-adrenoceptor blockade and anaesthesia. Beta-adrenoceptor antagonism during anaesthesia for coronary artery surgery.
    Manners JM; Walters FJ
    Anaesthesia; 1979 Jan; 34(1):3-9. PubMed ID: 34336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rebound phenomena following gradual withdrawal of chronic metoprolol treatment in patients with ischemic heart disease.
    Olsson G; Hjemdahl P; Rehnqvist N
    Am Heart J; 1984 Sep; 108(3 Pt 1):454-62. PubMed ID: 6475710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of beta-adrenoceptors in the expression of morphine withdrawal signs.
    Funada M; Suzuki T; Sugano Y; Tsubai M; Misawa M; Ueda H; Misu Y
    Life Sci; 1994; 54(8):PL113-8. PubMed ID: 7509021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug withdrawal symptoms following treatment with beta-receptor blockaders].
    Gilfrich HJ; Rahn KH
    Med Welt; 1981 Jun; 32(26):1036-7. PubMed ID: 6114382
    [No Abstract]   [Full Text] [Related]  

  • 33. Are selective beta-adrenoceptor blocking drugs an advantage?
    Kendall MJ
    J R Coll Physicians Lond; 1981 Jan; 15(1):33-40. PubMed ID: 6109778
    [No Abstract]   [Full Text] [Related]  

  • 34. The beta-adrenergic blockade withdrawal phenomenon.
    Prichard BN; Tomlinson B; Walden RJ; Bhattacharjee P
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S56-62. PubMed ID: 6188921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects.
    Ferro A; Hall JA; Dickerson JE; Brown MJ
    Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of the beta-adrenergic blocking drug Kö 1366 on haemodynamics in healthy volunteers and patients with ischaemic heart disease.
    Miyahara M; Fujise Y; Osanai S; Takada T
    Jpn Heart J; 1974 Sep; 15(5):455-68. PubMed ID: 4155008
    [No Abstract]   [Full Text] [Related]  

  • 37. Differential effects of long-term cardioselective and nonselective beta-receptor blockade on plasma catecholamines during and after physical exercise in hypertensive patients.
    Franz IW; Lohmann FW; Koch G
    J Cardiovasc Pharmacol; 1980; 2(1):35-44. PubMed ID: 6154203
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of withdrawal of beta-adrenergic blockade on intermittent claudication.
    Lepäntalo M; von Knorring J; Lindfors O; Scheinin TM
    Angiology; 1983 Jun; 34(6):401-11. PubMed ID: 6135376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adrenergic hypersensitivity after beta-blocker withdrawal.
    Ross PJ; Lewis MJ; Sheridan DJ; Henderson AH
    Br Heart J; 1981 Jun; 45(6):637-42. PubMed ID: 6114739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug information. Beta receptor blocking drugs in the treatment of hypertension. A review].
    Jensen HA; Rasmussen K
    Ugeskr Laeger; 1976 Nov; 138(47):2965-9. PubMed ID: 10660
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.